Evidence map›Paper›PMID 40382313›Full record

ArticleNature communications2025

Characteristic scales and adaptation in higher-order contagions.

Giulio Burgio, Guillaume St-Onge, Laurent Hébert-Dufresne

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Giulio BurgioDepartament d'Enginyeria Informàtica i Matemàtiques, Universitat Rovira i Virgili, Tarragona, Spain. giulioburgio@gmail.com.ORCID http://orcid.org/0000-0002-6333-4847
Guillaume St-OngeDepartment of Physics, the Roux Institute at Northeastern University, Portland, ME, USA.ORCID http://orcid.org/0000-0001-5415-3748
Laurent Hébert-DufresneVermont Complex Systems Institute, University of Vermont, Burlington, VT, USA.ORCID http://orcid.org/0000-0002-0008-3673

Funding

Using Dengue Controlled Human Infection Model to Identify Adaptive Immune Correlates of ProtectionP20GM125498 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Ellen Kozelka · 2018 to 2026
$24.9M
EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 945413Fonds de Recherche du Québec - Nature et Technologies (Quebec Fund for Research in Nature and Technology) 313475National Science Foundation (NSF) 2242829NIGMS NIH HHS P20 GM125498U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) P20GM125498
6 · The paper itself

Abstract

People organize in groups and contagions spread across them. A simple stochastic process, yet complex to model due to dynamical correlations within and between groups. Moreover, groups can evolve if agents join or leave in response to contagions. To address the lack of analytical models that account for dynamical correlations and adaptation in groups, we introduce the method of generalized approximate master equations. We first analyze how nonlinear contagions differ when driven by group-level or individual-level dynamics. We then study the characteristic levels of group activity that best describe the stochastic process and that optimize agents' ability to adapt to it. Naturally lending itself to study adaptive hypergraphs, our method reveals how group structure unlocks new dynamical regimes and enables distinct suitable adaptation strategies. Our approach offers a highly accurate model of binary-state dynamics on hypergraphs, advances our understanding of contagion processes, and opens the study of adaptive group-structured systems.

Identifiers

PMID40382313
PMCPMC12085611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.